Field effectiveness of pandemic and 2009-2010 seasonal vaccines against 2009-2010 a(H1N1) influenza: Estimations from surveillance data in France

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Pelat, Camille ^a,b   Falchi, Alessandra ^a,b   Carrat, Fabrice ^a,b,c   Mosnier, Anne ^d   Bonmarin, Isabelle ^e   Turbelin, Clément ^a,b   Vaux, Sophie ^e   van der Werf, Sylvie ^f,g,h   Cohen, Jean Marie ^d   Lina, Bruno ⁱ   Blanchon, Thierry ^a,b   Hanslik, Thomas ^b,j,k  

^a SORBONNE UNIVERSITÉ   (France)

^b INSERM   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d Open Rome Coordination Nationale des Groupes Régionaux d'Observation de la Grippe   (France)

^e INSTITUT DE VEILLE SANITAIRE   (France)

^f INSTITUT PASTEUR   (France)

^g CNRS   (France)

^h UNIVERSITÉ PARIS DESCARTES   (France)

ⁱ HOSPICES CIVILS DE LYON   (France)

^j HÔPITAL AMBROISE PARÉ   (France)

^k LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; Q PAN H1N1; UNCLASSIFIED DRUG;

2009 H1N1 INFLUENZA; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHILD; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DISEASE SURVEILLANCE; DRUG EFFICACY; FEMALE; FRANCE; HEALTH PROMOTION; HUMAN; INFANT; INFECTION PREVENTION; INFECTION RISK; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PANDEMIC INFLUENZA; PRESCHOOL CHILD; SCHOOL CHILD; SEASONAL INFLUENZA; HEALTH SURVEY; IMMUNOLOGY; INCIDENCE; INFLUENZA; INFLUENZA VIRUS A H1N1; MIDDLE AGED; PANDEMIC; REPRODUCIBILITY; SEASON; TREATMENT OUTCOME; VIROLOGY;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FRANCE; HUMANS; INCIDENCE; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MIDDLE AGED; PANDEMICS; POPULATION SURVEILLANCE; REPRODUCIBILITY OF RESULTS; SEASONS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79955919075     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019621     Document Type: Article

References (43)

1. Haut Conseil de la Santé Publique (2009) List of prioritary target groups for pandemic vaccination (updated December 1, 2009). Available: http://www.sante-sports.gouv.fr/IMG/pdf/Personnes_invitees_a_se_faire_vacciner_par_ordre_de_priorite.pdf. Accessed 2011 Jan 10.
2. Haut Conseil de la Santé Publique (2009) Recommendations on the sanitary priorities of influenza A(H1N1)v pandemic vaccines (September 7, 2009). Available: http://www.sante-sports.gouv.fr/IMG/pdf/Personnes_invitees_a_se_faire_vacciner_par_ordre_de_priorite.pdf. Accessed 2011 Jan 10.
3. Valleron AJ, Bouvet E, Garnerin P, Menares J, Heard I, et al. (1986) A computer network for the surveillance of communicable diseases: the French experiment. Am J Public Health 76: 1289-1292.
4. Rousset D, Bouscambert DM, Enouf V, Valette M, Cohen J, et al. (2011) A(H1N1)2009 pandemic in France: epidemiological features based on virological surveillance. Influenza and Other Respiratory Viruses Options VII Conference Proceedings In press.
5. Orenstein WA, Bernier RH, Dondero TJ, Hinman AR, Marks JS, et al. (1985) Field evaluation of vaccine efficacy. Bull World Health Organ 63: 1055-1068.
6. Orenstein WA, Bernier RH, Hinman AR, (1988) Assessing vaccine efficacy in the field. Further observations. Epidemiol Rev 10: 212-241.
7. Skowronski DM, Janjua NZ, De Serres G, Hottes TS, Dickinson JA, et al. (2011) Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009. BMJ 342: c7297.
8. Valenciano M, Kissling E, Cohen JM, Oroszi B, Barret AS, et al. (2011) Estimates of Pandemic Influenza Vaccine Effectiveness in Europe, 2009-2010: Results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) Multicentre Case-Control Study. PLoS Med 8: e1000388.
9. Hannoun C, Dab W, Cohen JM, (1989) A new influenza surveillance system in France: the Ile-de-France "GROG". 1. Principles and methodology. Eur J Epidemiol 5: 285-293.
10. Falchi A, Varesi L, Arena C, Leveque N, Renois F, et al. (2009) Co-circulation of two genetically distinct sub-groups of A/H3N2 influenza strains during the 2006-2007 epidemic season in Corsica Island, France. J Clin Virol 45: 265-268.
11. Vaux S, Van Cauteren D, Guthmann JP, Le Strat Y, Vaillant V, et al. (2011) Influenza vaccination coverage against seasonal and pandemic influenza and their determinants in France: a cross-sectional survey. BMC Public Health 11: 30.
12. Farrington CP, (1993) Estimation of vaccine effectiveness using the screening method. Int J Epidemiol 22: 742-746.
13. Cox RJ, Brokstad KA, Ogra P, (2004) Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines. Scand J Immunol 59: 1-15.
14. Halloran ME, Longini IM Jr, (2001) Using validation sets for outcomes and exposure to infection in vaccine field studies. Am J Epidemiol 154: 391-398.
15. Scharfstein DO, Halloran ME, Chu H, Daniels MJ, (2006) On estimation of vaccine efficacy using validation samples with selection bias. Biostatistics 7: 615-629.
16. Orenstein EW, De Serres G, Haber MJ, Shay DK, Bridges CB, et al. (2007) Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. Int J Epidemiol 36: 623-631.
17. Mangtani P, Cumberland P, Hodgson CR, Roberts JA, Cutts FT, et al. (2004) A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database. J Infect Dis 190: 1-10.
18. Vu T, Farish S, Jenkins M, Kelly H, (2002) A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. Vaccine 20: 1831-1836.
19. Fireman B, Lee J, Lewis N, Bembom O, van der Laan M, et al. (2009) Influenza vaccination and mortality: differentiating vaccine effects from bias. Am J Epidemiol 170: 650-656.
20. Eurich DT, Marrie TJ, Johnstone J, Majumdar SR, (2008) Mortality reduction with influenza vaccine in patients with pneumonia outside "flu" season: pleiotropic benefits or residual confounding? Am J Respir Crit Care Med 178: 527-533.
21. Rivetti D, Jefferson T, Thomas R, Rudin M, Rivetti A, et al. (2006) Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev 3: CD004876.
22. Baxter R, Ray GT, Fireman BH, (2010) Effect of influenza vaccination on hospitalizations in persons aged 50 years and older. Vaccine.
23. Hardelid P, Fleming DM, McMenamin J, Andrews N, Robertson C, et al. (2011) Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland 2009-2010. Euro Surveill 16.
24. Song JY, Cheong HJ, Heo JY, Noh JY, Choi WS, et al. (2011) Effectiveness of the pandemic influenza A/H1N1 2009 monovalent vaccine in Korea. Vaccine 29: 1395-1398.
25. Simpson CR, Ritchie LD, Robertson C, Sheikh A, McMenamin J, (2010) Vaccine effectiveness in pandemic influenza- primary care reporting (VIPER): an observational study to assess the effectiveness of the pandemic influenza A (H1N1)v vaccine. Health Technol Assess 14: 313-346.
26. Wichmann O, Stocker P, Poggensee G, Altmann D, Walter D, et al. (2010) Pandemic influenza A(H1N1) 2009 breakthrough infections and estimates of vaccine effectiveness in Germany 2009-2010. Euro Surveill 15.
27. Furuse Y, Suzuki A, Kishi M, Galang HO, Lupisan SP, et al. (2004) Detection of novel respiratory viruses from influenza-like illness in the Philippines. J Med Virol 82: 1071-1074.
28. Laguna-Torres VA, Gomez J, Aguilar PV, Ampuero JS, Munayco C, et al. (2010) Changes in the viral distribution pattern after the appearance of the novel influenza A H1N1 (pH1N1) virus in influenza-like illness patients in Peru. PLoS One 5: e11719.
29. Plennevaux E, Blatter M, Cornish MJ, Go K, Kirby D, et al. (2011) Influenza A (H1N1) 2009 two-dose immunization of US children: an observer-blinded, randomized, placebo-controlled trial. Vaccine 29: 1569-1575.
30. Viboud C, Simonsen L, (2009) Does Seasonal Influenza Vaccination Increase the Risk of Illness with the 2009 A/H1N1 Pandemic Virus? Plos medicine 7: e1000259.
31. Johns MC, Eick AA, Blazes DL, Lee SE, Perdue CL, et al. (2010) Seasonal influenza vaccine and protection against pandemic (H1N1) 2009-associated illness among US military personnel. PLoS One 5: e10722.
32. Janjua NZ, Skowronski DM, Hottes TS, Osei W, Adams E, et al. (2010) Seasonal influenza vaccine and increased risk of pandemic A/H1N1-related illness: first detection of the association in British Columbia, Canada. Clin Infect Dis 51: 1017-1027.
33. Carcione D, Giele C, Goggin LS, Kwan KS, Smith DW, et al. (2010) Association between 2009 seasonal influenza vaccine and influenza-like illness during the 2009 pandemic: preliminary results of a large household transmission study in Western Australia. Euro Surveill 15.
34. Puig-Barbera J, Arnedo-Pena A, Pardo-Serrano F, Tirado-Balaguer MD, Perez-Vilar S, et al. (2010) Effectiveness of seasonal 2008-2009, 2009-2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellon, Spain. A test-negative, hospital-based, case-control study. Vaccine 28: 7460-7467.
35. Carlson SJ, Durrheim DN, Dalton CB, (2010) Flutracking provides a measure of field influenza vaccine effectiveness, Australia, 2007-2009. Vaccine 28: 6809-6810.
36. Jefferies S, Earl D, Berry N, Blackmore T, Rooker S, et al. (2011) Effectiveness of the 2009 seasonal influenza vaccine against pandemic influenza A(H1N1)2009 in healthcare workers in New Zealand, June-August 2009. Euro Surveill 16.
37. Orellano PW, Reynoso JI, Carlino O, Uez O, (2010) Protection of trivalent inactivated influenza vaccine against hospitalizations among pandemic influenza A (H1N1) cases in Argentina. Vaccine 28: 5288-5291.
38. Oshitani H, Saito R, Seki N, Tanabe N, Yamazaki O, et al. (2000) Influenza vaccination levels and influenza-like illness in long-term-care facilities for elderly people in Niigata, Japan, during an influenza A (H3N2) epidemic. Infect Control Hosp Epidemiol 21: 728-730.
39. Kawai N, Ikematsu H, Iwaki N, Satoh I, Kawashima T, et al. (2003) A prospective, Internet-based study of the effectiveness and safety of influenza vaccination in the 2001-2002 influenza season. Vaccine 21: 4507-4513.
40. Millot JL, Aymard M, Bardol A, (2002) Reduced efficiency of influenza vaccine in prevention of influenza-like illness in working adults: a 7 month prospective survey in EDF Gaz de France employees, in Rhone-Alpes, 1996-1997. Occup Med (Lond) 52: 281-292.
41. Ochiai H, Fujieda M, Ohfuji S, Fukushima W, Kondo K, et al. (2009) Inactivated influenza vaccine effectiveness against influenza-like illness among young children in Japan--with special reference to minimizing outcome misclassification. Vaccine 27: 7031-7035.
42. Nichol KL, D'Heilly S, Ehlinger EP, (2008) Influenza vaccination among college and university students: impact on influenzalike illness, health care use, and impaired school performance. Arch Pediatr Adolesc Med 162: 1113-1118.
43. Call SA, Vollenweider MA, Hornung CA, Simel DL, McKinney WP, (2005) Does this patient have influenza? JAMA 293: 987-997.